References
- Meade T W, Brozovic M, Chakrabarti R, Haines A P, Imeson J D, Mellows S, et al. Haemostatic function and cardiovascular death: Principal results of The Northwick Park Heart Study. Lancet 1993; ii: 533–7
- Hultin M B. Fibrinogen and factor VII as risk factors in vascular disease. Prog Hemost Thromb 1993; 10: 215–41
- Hoffman C J, Miller R H, Hultin M B. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1993; 12: 267–70
- Plu-Bureau G, Scarabin P Y, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and oral contraceptives. Thromb Res 1993; 70: 275–80
- Suzuki T, Yamauchi K, Matsushita T, Furumichi T, Furui H, Tsuzuki J, et al. Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1993; 14: 731–6
- Bruckert E, de Sousa J C, Giral P, Soria C, Chapman M J, Caen J, et al. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridaemic hypercholesterolaemia. Atherosclerosis 1993; 75: 129–34
- Hoffman C, Shah A, Sodums M, Hultin M B. Factor VII activity state in coronary artery disease. J Lab Clin Med 1993; 111: 475–81
- Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1993; 80: 227–33
- De Sousa J C, Bruckert E, Soria C, Caen J P. Phospholipase C sensitive factor VII activity and factor VII antigen in hypertriglyceridaemia. Nouv Rev Fr Hematol 1993; 31: 13–5
- Hoffman C J, Miller R H, Lawson W E, Hultin M B. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol 1993; 14: 941–6
- De Sousa J C, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, et al. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1993; 51: 165–73
- Miller G J, Martin J C, Mitropoulos K A, Reeves B EA, Thompson R L, Meade T W, et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1993; 86: 163–71
- Marckmann P, Sandström B, Jespersen J. Dietary effects on circadian fluctuations in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993; 101: 225–34
- Mitropoulos K A, Esnouf M P, Meade T W. Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Atherosclerosis 1993; 63: 43–52
- Miller G J, Walter S J, Stirling Y, Thompson S G, Esnouf M P, Meade T W. Assay of factor VII activity by two techniques: evidence for increased conversion of FVII to FVIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1993; 59: 249–58
- Douglas A S. Anticoagulant therapy. Blackwell Scientific, Oxford 1962; 16–18
- Brozovic M, Stirling Y, Harricks C, North W RS, Meade T W. Factor VII in an industrial population. Br J Haematol 1993; 28: 381–91
- Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1993; i: 307–10